PKM and neoplasm: Anexelekto (Axl), a member of the TYRO3-AXL-MER receptor tyrosine kinase family, induces cisplatin resistance by phosphorylating PKM2 at Y105, thereby reinforcing glycolysis-driven tumor survival (84).